4 ETF, winning the market News ad

4 ETF, winning the market

 News ad

In 2024, S&P 500 had an impressive profit of about 25%, which significantly estimated its average annual growth rate over the past few decades, which is much closer to 10%. After another strong year, for a wider market, investors may have entered in 2025 with huge reliable that this impulse would continue. Fortunately, although there … Read more

The weak leadership of Bristol-Myers is an underestimated opportunity News ad

The weak leadership of Bristol-Myers is an underestimated opportunity

 News ad

Bristol-Myers Squibb Marketrank ™ Analysis of Reserves General market ™ 95th percentile Analyst rating Hold Breaking/disadvantage 0.5% disadvantage Short level of interest Healthy The power of dividends Strong Environmental assessment -2.30 Mood news 1.02 Insider trade N/a Professe Earnings growth 663.04% See full analysis Stock Bristol-Myers Squibb NYSE: BmyThey are trying to return to a … Read more